- Home
- IMCR vs FCF Comparison
IMCR vs FCF Comparison
Compare IMCR & FCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- FCF
- Stock Information
- Founded
- IMCR 2008
- FCF 1934
- Country
- IMCR United Kingdom
- FCF United States
- Employees
- IMCR N/A
- FCF N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- FCF Major Banks
- Sector
- IMCR Health Care
- FCF Finance
- Exchange
- IMCR Nasdaq
- FCF Nasdaq
- Market Cap
- IMCR 1.4B
- FCF 1.6B
- IPO Year
- IMCR 2021
- FCF N/A
- Fundamental
- Price
- IMCR $29.58
- FCF $15.49
- Analyst Decision
- IMCR Buy
- FCF Buy
- Analyst Count
- IMCR 12
- FCF 7
- Target Price
- IMCR $63.00
- FCF $19.36
- AVG Volume (30 Days)
- IMCR 372.8K
- FCF 920.3K
- Earning Date
- IMCR 05-07-2025
- FCF 04-22-2025
- Dividend Yield
- IMCR N/A
- FCF 3.36%
- EPS Growth
- IMCR N/A
- FCF N/A
- EPS
- IMCR N/A
- FCF 1.39
- Revenue
- IMCR $310,202,000.00
- FCF $448,502,000.00
- Revenue This Year
- IMCR $18.97
- FCF $11.90
- Revenue Next Year
- IMCR $8.43
- FCF $9.80
- P/E Ratio
- IMCR N/A
- FCF $11.14
- Revenue Growth
- IMCR 24.36
- FCF N/A
- 52 Week Low
- IMCR $27.19
- FCF $12.41
- 52 Week High
- IMCR $66.00
- FCF $19.96
- Technical
- Relative Strength Index (RSI)
- IMCR 49.95
- FCF 38.82
- Support Level
- IMCR $28.92
- FCF $15.43
- Resistance Level
- IMCR $30.04
- FCF $15.99
- Average True Range (ATR)
- IMCR 1.49
- FCF 0.31
- MACD
- IMCR 0.10
- FCF 0.02
- Stochastic Oscillator
- IMCR 53.71
- FCF 26.29
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About FCF First Commonwealth Financial Corporation
First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.